This inventor holds 1 USPTO granted patent. Top assignee: Restore Vision Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Melissa Kleman: Innovator in Ophthalmic Formulations
Introduction
Melissa Kleman is a notable inventor based in The Woodlands, TX (US). She has made significant contributions to the field of ophthalmology through her innovative work in pharmaceutical formulations. Her research focuses on developing effective treatments for presbyopia, a common age-related vision condition.
Latest Patents
Melissa Kleman holds a patent for "Ophthalmic formulations for the treatment of presbyopia." This patent discloses a pharmaceutical formulation that includes a nanoparticle composition designed for controlled delivery of therapeutic agents. The formulation comprises a plurality of coated nanoparticles, where the core particle contains a solid pharmaceutical agent or its salt. The patent also outlines methods for treating various ophthalmic conditions by administering a therapeutically effective amount of the disclosed formulation.
Career Highlights
Throughout her career, Melissa has demonstrated a commitment to advancing ophthalmic treatments. Her work at Restore Vision Inc. has positioned her as a key player in the development of innovative solutions for vision-related issues. Her dedication to research and development has led to the successful patenting of her groundbreaking formulation.
Collaborations
Melissa collaborates with talented professionals in her field, including Arthur A Medina, Jr. and Sharron Acosta. These partnerships enhance her research efforts and contribute to the advancement of ophthalmic therapies.
Conclusion
Melissa Kleman is a pioneering inventor whose work in ophthalmic formulations is making a significant impact in the treatment of presbyopia. Her innovative approach and dedication to research continue to drive advancements in the field of ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile